This product is a recombinant human antibody IEI-E3 that recognizes MDA-ApoB100. IEI-E3 is a human antibody towards one oxidized fragment of apolipoprotein B and can be used for treatment study of atherosclerosis.
Figure 6 ELISA based analysis of binding of 2D03 and IEI-E3 antibodies to MDA-modified human ApoB-100.
Control corresponds to binding of FITC-8 antibody to the same antigen. Affinities were determined by Biacore analysis.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-0257CQ | Human Anti-MDA-ApoB100 Recombinant Antibody (clone IEI-D8) | ELISA, Inhib | Human IgG1 |
HPAB-0258CQ | Human Anti-MDA-ApoB100 Recombinant Antibody (clone KTT-B8) | ELISA, Inhib | Human IgG1 |
HPAB-0259CQ | Human Anti-MDA-ApoB100 Recombinant Antibody (clone 2D03) | ELISA, IHC | Human IgG1 |
There are currently no Customer reviews or questions for HPAB-0256CQ. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.